Delivery Order SPE2DB20D3101-SPE2DB25FRUM7
- Not listed
- This delivery order, valued at $1,653.26, was awarded to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Strong Iodine Solution in 14ml quantities. The order is part of a competitive, non-set-aside procurement funded by the Defense Logistics Agency (DLA), a defense-focused federal agency responsible for supplying medical and pharmaceutical products to the Department of Defense. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 14mL bottles of strong iodine solution. The delivery order, valued at $1,548.00, has a completion date of March 6, 2024 and was awarded on February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program....
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,740.75 to AmerisourceBergen Drug Corp on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,649.26 to AmerisourceBergen Drug Corp on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The work will be performed at the contractor's corporate office location...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $3,629.35 to AmerisourceBergen Drug Corp on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor is headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, with a ceiling value of $1,157.73 and an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is performed from the contractor's corporate office in...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,132.80 to AmerisourceBergen Drug Corp on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,565.18 to AmerisourceBergen Drug Corp on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vehicle running through December 2026. The contract is being performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,063.72 to AmerisourceBergen Drug Corp on September 25, 2025, for pharmaceutical and medical supply products. This is an unset-aside, competitively awarded contract with firm fixed pricing, with ultimate completion scheduled for September 26, 2025. The order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.9...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,140.36 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued under a competitive, non-set-aside procurement, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026....
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUM7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,289.64 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of strong iodine solution in 14ml units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 26, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company holds a significant competitive position within the DLA's Medical Supply Chain and demonstrates extensive capability in fulfilling federal medical supply requirements across multiple therapeutic domains. Performance of this delivery order will take place at the company's Conshohocken facility.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 9/5/25 |